A Case of Organizing Pneumonia Following Azacitidine Treatment for Myelodysplastic Syndrome
Organizing pneumonia (OP) is a lung pathology mainly affecting distal lung structures. Its etiology is often unknown, in which case it is termed cryptogenic organizing pneumonia (COP). Of those cases of OP with an identified cause, the usual culprits include infections, medications, and radiation...
Main Authors: | Kelly Ann Hutchinson, Carole-Ann Hébert, Ajay Rajaram, Pierre-Olivier Fiset, Kevin Schwartzman |
---|---|
Format: | Article |
Language: | English |
Published: |
McGill University
2023-05-01
|
Series: | McGill Journal of Medicine |
Subjects: | |
Online Access: | https://mjm.mcgill.ca/article/view/983 |
Similar Items
-
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome
by: Francesco D’Alò, et al.
Published: (2021-04-01) -
Combination therapy with venetoclax and azacitidine for the treatment of myelodysplastic syndromes with DDX41 mutations
by: Xin Wang, et al.
Published: (2024-12-01) -
An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum
by: Esra Turan Erkek, et al.
Published: (2016-02-01) -
Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
by: Carlo Pescia, et al.
Published: (2021-10-01) -
Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine
by: Eri Takada, et al.
Published: (2024-02-01)